Table 4 Healthcare resource use since diagnosis among patients with a primary diagnosis of CSU with or without angioedema
EU Region | C/SA Region | |||||
|---|---|---|---|---|---|---|
Healthcare Resource | CSU with angioedema (n = 1721) | CSU without angioedema (n = 1760) | Significance Test Statistic | CSU with angioedema (n = 250) | CSU without angioedema (n = 182) | Significance Test Statistic |
Emergency room | ||||||
Proportion of patients | 40.4% | 20.0% | Chi2 = 175.474; Ρ < 0.001 | 54.0% | 25.8% | Chi2 = 38.379; P < 0.001 |
Frequency of visits | 4.0 (8.1) | 2.5 (4.1) | F = 9.70; Ρ = 0.002 | 8.0 (19.0) | 2.1 (8.9) | F = 13.42; P < 0.001 |
Hospitalizations | ||||||
Proportion of patients | 29.1% | 15.7% | Chi2 = 90.023; Ρ < 0.001 | 11.4% | 5.2% | Chi2 = 4.913; P = 0.027 |
Frequency of visits | 2.3 (3.7) | 1.5 (1.2) | F = 9.69; Ρ = 0.002 | 0.4 (2.1) | 0.2 (1.3) | F = 1.86; P = 0.173 |
General practitioner | ||||||
Proportion of patients | 61.9% | 53.5% | Chi2 = 24.977; Ρ < 0.001 | 38.1% | 32.2% | Chi2 = 1.547; P = 0.214 |
Frequency of visits | 9.5 (18.4) | 5.8 (9.0) | F = 27.72; Ρ < 0.001 | 2.3 (5.0) | 1.1 (2.5) | F = 8.34; P = 0.004 |
Dermatologist or allergist | ||||||
Proportion of patients | 53.2% | 41.2% | Chi2 = 50.552; Ρ < 0.001 | 54.2% | 54.0% | Chi2 = 0.002;P = 0.966 |
Frequency of visits | 7.9 (26.6) | 7.0 (22.3) | F = 0.41; P = 0.523 | 5.3 (11.3) | 5.9 (20.6) | F = 0.13; P = 0.715 |